Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trial Dehydroepiandrosterone
Lust, John Anthony
Mayo Clinic, Rochester, Rochester, MN, United States
Search 4 grants from John Lust
Search grants from Mayo Clinic, Rochester
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Development of brain-computer interface methods to influence brain dynamics in stuttering
Understanding the basis of mRNA selectivity using ribosomes lacking Rps26
Los Angeles HIV Prevention Trials Unit
Anesthesiology Center for Research and Teaching
Growth and Characterization of Pulmonary Endocrine Cells
Recently added grants:
Anastrozole in Pulmonary Arterial Hypertension (AIPH2) - CCC (Lead)
Anastrozole in Pulmonary Arterial Hypertension (AIPH2) - DCC
Biology of ?-linked glycosylceramides in the immune system
Genetics of Endocytic Trafficking in the Drosophila Eye
Estrogen signaling and energy metabolism in pulmonary arterial hypertension
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN065125-000
Application #
2371351
Study Section
Project Start
1996-09-27
Project End
Budget Start
1996-09-27
Budget End
2001-09-29
Support Year
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Related projects
NIH 2005
N01 CN
Phase 2 Clinical Trial-Dehydroepiandrosterone in Monoclonal Gammopathy-261065125
/ Mayo Clinic, Rochester
NIH 1996
N01 CN
Phase II Clinical Trial Dehydroepiandrosterone
Lust, John Anthony / Mayo Clinic, Rochester
Comments
Be the first to comment on this grant